ABCL
Price
$3.33
Change
-$0.08 (-2.35%)
Updated
Jun 23 closing price
Capitalization
993.95M
49 days until earnings call
CDXS
Price
$2.36
Change
+$0.07 (+3.06%)
Updated
Jun 23 closing price
Capitalization
195.51M
37 days until earnings call
Interact to see
Advertisement

ABCL vs CDXS

Header iconABCL vs CDXS Comparison
Open Charts ABCL vs CDXSBanner chart's image
AbCellera Biologics
Price$3.33
Change-$0.08 (-2.35%)
Volume$5.32M
Capitalization993.95M
Codexis
Price$2.36
Change+$0.07 (+3.06%)
Volume$528.93K
Capitalization195.51M
ABCL vs CDXS Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CDXS commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and CDXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (ABCL: $3.33 vs. CDXS: $2.36)
Brand notoriety: ABCL and CDXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 103% vs. CDXS: 69%
Market capitalization -- ABCL: $993.95M vs. CDXS: $195.51M
ABCL [@Biotechnology] is valued at $993.95M. CDXS’s [@Biotechnology] market capitalization is $195.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCDXS’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CDXS’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than CDXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while CDXS’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • CDXS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CDXS is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +5.38% price change this week, while CDXS (@Biotechnology) price change was +5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.24%. For the same industry, the average monthly price growth was +27.91%, and the average quarterly price growth was +12.28%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

CDXS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-2.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($994M) has a higher market cap than CDXS($196M). ABCL YTD gains are higher at: 13.652 vs. CDXS (-50.524). CDXS has higher annual earnings (EBITDA): -62.28M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. CDXS (59.8M). CDXS has less debt than ABCL: CDXS (59.5M) vs ABCL (67.8M). CDXS has higher revenues than ABCL: CDXS (49.8M) vs ABCL (23.1M).
ABCLCDXSABCL / CDXS
Capitalization994M196M507%
EBITDA-211.2M-62.28M339%
Gain YTD13.652-50.524-27%
P/E RatioN/AN/A-
Revenue23.1M49.8M46%
Total Cash605M59.8M1,012%
Total Debt67.8M59.5M114%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCDXS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
76%
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAGAX32.67N/A
N/A
Gabelli Global Rising Income and Div A
NBGUX28.71N/A
N/A
Neuberger Berman Large Cap Growth Adv
HSLYX44.77N/A
N/A
Hartford Small Cap Growth Y
MRSKX25.06N/A
N/A
MFS Research International R6
RMQCX466.20N/A
N/A
Rydex Monthly Rbl NASDAQ-100® 2x Strt C

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-2.35%
CRSP - ABCL
62%
Loosely correlated
+2.94%
RXRX - ABCL
58%
Loosely correlated
-3.78%
ABSI - ABCL
57%
Loosely correlated
-1.08%
BEAM - ABCL
56%
Loosely correlated
-0.30%
VCYT - ABCL
56%
Loosely correlated
+1.21%
More

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
+3.06%
BEAM - CDXS
49%
Loosely correlated
-0.30%
PRAX - CDXS
49%
Loosely correlated
-1.68%
DNLI - CDXS
48%
Loosely correlated
-1.94%
CRSP - CDXS
47%
Loosely correlated
+2.94%
ABCL - CDXS
46%
Loosely correlated
-2.35%
More